[뉴스]미장 Key-Pre Market Stock : 비트코인 : 와이고수

Key Pre-Market Stock Trends on October 15, 2025

Rising Stocks:

SDOT (+146.44%): Sdot Group shares surged after President Trump stated that the U.S. might end its edible oil business related to China.

VERI (+48.53%): Veritone announced VDR contracts with major hyperscalers and updated its Q3 earnings outlook.

BTDR (+14.96%): Bitdeer released production and operations updates for September 2025.

PZZA (+12.80%): Reuters reported that APO is attempting to reacquire PZZA.

HI (+12.19%): Hillenbrand is set to be acquired by Lone Star for about $3.8 billion.

DLTR (+7.85%): Dollar Tree’s earnings forecast for fiscal year 2026 exceeded expectations.

LEU (+7.26%): Centrus scheduled a conference call on November 6 at 8:30 AM (ET).

CRDO (+5.24%): Credo joined Arm Total Design to accelerate development of AI data center customized silicon.

BG (+5.05%): Bunge provided 2025 outlook and restructured reporting following the Viterra merger.

ASML (+4.63%): Earnings surprise with revenue below expectations. Q4 and fiscal 2025 revenue guidance aligned with market expectations.

BAC (+4.59%): Bank of America reported an earnings surprise of $0.11 per share and strong revenue, providing Q4 net interest income (NII) guidance.

ALAB (+4.36%): Astera Labs rose pre-market on news of a new Arm partnership.

MS (+4.07%): Morgan Stanley reported an earnings surprise of $0.70 per share and strong revenue.

VRT (+3.69%): Vertiv and Edzitek signed a technology cooperation agreement.

AMD (+2.76%): HSBC maintained a buy rating.

NVDA (+2.48%): HSBC upgraded to 'buy' based on expectations of recovering demand in China.

Declining Stocks:

KARO (-6.44%): Karooooo fell after revising subscription revenue growth rate from 15% to 20%.

APEI (-6.88%): American Public Education expects about $10 million revenue loss due to government shutdown.

PNC (-2.76%): Despite an earnings surprise of $0.30 per share and strong revenue, Q4 revenue guidance fell short of expectations.

ABT (-2.99%): Declined as quarterly results missed market expectations.